カテゴリー： Inkwood Research, 世界, 医療/バイオ

神経血管デバイス/神経内視鏡手術の世界市場2023年〜2032年

◆英語タイトル：GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032

Inkwood Researchが発行した調査報告書（INK23SEP011）◆商品コード：INK23SEP011
◆発行会社（リサーチ会社）：Inkwood Research
◆発行日：2023年8月4日
◆ページ数：233
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

主な調査結果世界の神経血管デバイス/神経内視鏡手術市場は予測期間中にCAGR 5.23%を記録すると推測しています。この市場の成長要因は、世界中で神経疾患の発生率が上昇していること、低侵襲手術への嗜好が高まっていること、神経血管疾患に対する高齢者人口の脆弱性、神経血管疾患のリスクを増大させる基礎疾患などによるものです。

市場インサイト
神経血管疾患は、脳や脊髄に酸素を含む血液を供給する血管に関連しています。血流に障害が生じると脳機能が低下し、生命を脅かす危険性があります。このような状態では、早急な医療処置が不可欠です。頭蓋内狭窄、高悪玉コレステロール、高血圧、糖尿病などの因子は神経血管疾患の原因となります。

例えば、悪玉コレステロール値が高くなると、頭蓋内動脈にプラークが沈着して狭窄が生じ、虚血性脳卒中のリスクが高まります。このような状態の管理には神経血管デバイスを用いた迅速な治療が不可欠であり、市場の成長を牽引しています。さらに、虚血性脳卒中の主な原因である高血圧は、脳を供給する動脈を塞ぐ血栓を引き起こし、脳卒中を引き起こします。その結果、神経血管疾患のリスク増大につながる基礎疾患が、予測期間中の世界の神経血管デバイス/神経内視鏡手術市場の成長に貢献すると予想されます。

地域別インサイト
世界の神経血管デバイス/神経内視鏡手術市場の成長評価には、欧州、アジア太平洋地域、北米、その他の地域の分析が含まれます。北米は2032年までに最も高い収益シェアを獲得する見込みで、同地域の成長は神経血管疾患の増加と最先端医療技術への高投資に起因しています。

競合インサイト
世界の神経血管デバイス/神経内視鏡手術市場の主要企業は、市場シェアを拡大するために様々な戦略を実施しているため、予測期間中に業界の競争が激化すると考えられます。したがって、市場の上位企業には、Medtronic Inc、Memry Corporation、Penumbra Inc、MicroPort Scientific Corporationなどがあります。

本レポートの内容は以下の通りです：
- 市場全体の主要調査結果の調査
- 市場ダイナミクスの戦略的内訳（促進要因、抑制要因、機会、課題）
- 全セグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
- 市場セグメンテーション：主要セグメントの徹底的な評価と市場予測
- 地域別分析：言及された地域および国レベルのセグメントを市場シェアとともに評価
- 主要分析：ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要購買基準など
- 競争状況：要因や市場シェアなどに基づく主要企業の理論的説明
- 企業情報：詳細な会社概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など

1. 調査範囲・調査方法
2. エグゼクティブサマリー
3. 市場ダイナミクス
4. 主要分析
5. 製品別市場分析
6. 用途別市場分析
7. 地域別分析
8. 競争状況

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1.STUDY OBJECTIVES
1.2.METHODOLOGY
1.3.ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1.MARKET SIZE & ESTIMATES
2.2.MARKET OVERVIEW
2.3.SCOPE OF STUDY
2.4.CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
2.5.MAJOR MARKET FINDINGS
2.5.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
2.5.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
2.5.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
3. MARKET DYNAMICS
3.1.KEY DRIVERS
3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
3.2.KEY RESTRAINTS
3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
3.2.2. LACK OF TRAINED NEUROSURGEONS
4. KEY ANALYTICS
4.1.KEY MARKET TRENDS
4.2.PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3.GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
4.3.3. GROWTH PROSPECT MAPPING FOR THAILAND
4.3.4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
4.4.MARKET MATURITY ANALYSIS
4.5.MARKET CONCENTRATION ANALYSIS
4.6.VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1.EMBOLIZATION DEVICES
5.1.1. EMBOLIC COILS
5.1.1.1. COATED DETACHABLE COILS
5.1.1.2. BARE DETACHABLE COILS
5.1.2. COIL ASSIST STENT
5.1.3. CLIPPINGS
5.1.4. COIL ASSIST BALLOON
5.2.ACCESSORY DEVICES
5.2.1. MICROCATHETERS
5.2.2. MICRO GUIDEWIRES
5.3.REVASCULARIZATION DEVICES
5.3.1. CAROTID ARTERY STENTS
5.3.2. FLOW DIVERSION STENTS
5.4.THROMBECTOMY DEVICES
5.4.1. CLOT RETRIEVAL DEVICES
5.4.2. SUCTION AND ASPIRATION DEVICES
5.4.3. SNARES
5.5.EMBOLIC PROTECTION DEVICES
5.5.1. BALLOON OCCLUSION DEVICES
5.5.2. DISTAL FILTER DEVICES
6. MARKET BY APPLICATION
6.1.ANEURYSM
6.2.ISCHEMIC STROKE
6.3.STENOSIS
6.4.ARTERIOVENOUS MALFORMATION (AVM)
6.5.OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1.NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.1.3. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.1.4. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. UNITED STATES
7.1.6.1.1. UNITED STATES NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.2. CANADA
7.1.6.2.1. CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.2.3. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.2.4. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.2.5. KEY PLAYERS IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.2.6. COUNTRY ANALYSIS
7.2.6.1. UNITED KINGDOM
7.2.6.1.1. UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.2. GERMANY
7.2.6.2.1. GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.3. FRANCE
7.2.6.3.1. FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.4. ITALY
7.2.6.4.1. ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.5. SPAIN
7.2.6.5.1. SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.6. POLAND
7.2.6.6.1. POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.7. BELGIUM
7.2.6.7.1. BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.8. REST OF EUROPE
7.2.6.8.1. REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.3.3. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.3.4. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.3.5. KEY PLAYERS IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.3.6. COUNTRY ANALYSIS
7.3.6.1. CHINA
7.3.6.1.1. CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.2. JAPAN
7.3.6.2.1. JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.3. INDIA
7.3.6.3.1. INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.4. SOUTH KOREA
7.3.6.4.1. SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.5. INDONESIA
7.3.6.5.1. INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.6. THAILAND
7.3.6.6.1. THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.7. VIETNAM
7.3.6.7.1. VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.8. AUSTRALIA & NEW ZEALAND
7.3.6.8.1. AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.9. REST OF ASIA-PACIFIC
7.3.6.9.1. REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.4.REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.4.3. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.4.4. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.4.5. KEY PLAYERS IN REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.4.6. REGIONAL ANALYSIS
7.4.6.1. LATIN AMERICA
7.4.6.1.1. LATIN AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.4.6.2. MIDDLE EAST & AFRICA
7.4.6.2.1. MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1.KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2.COMPANY PROFILES
8.2.1. ACANDIS GMBH
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT LIST
8.2.2. ASAHI INTECC
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT LIST
8.2.3. BALT
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCT LIST
8.2.4. B BRAUN MELSUNGEN AG
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INTEGER HOLDINGS CORPORATION
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JOHNSON & JOHNSON (CERENOVUS)
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT LIST
8.2.6.3. STRENGTHS & CHALLENGES
8.2.7. KANEKA CORPORATION
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT LIST
8.2.8. MEDTRONIC INC
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MEMRY CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT LIST
8.2.10. MICROPORT SCIENTIFIC CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. PENUMBRA INC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT LIST
8.2.12. PHENOX INC
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCT LIST
8.2.12.3. STRENGTHS & CHALLENGES
8.2.13. RAPID MEDICAL
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCT LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. SENSOME
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCT LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. STRYKER CORPORATION
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCT LIST
8.2.15.3. STRENGTHS & CHALLENGES
8.2.16. TERUMO CORPORATION
8.2.16.1. COMPANY OVERVIEW
8.2.16.2. PRODUCT LIST
8.2.16.3. STRENGTHS & CHALLENGES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY
TABLE 2: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL EMBOLIC COILS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL EMBOLIC COILS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL BARE DETACHABLE COILS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL BARE DETACHABLE COILS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL COIL ASSIST STENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL COIL ASSIST STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL CLIPPINGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL CLIPPINGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL COIL ASSIST BALLOON MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL COIL ASSIST BALLOON MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL MICROCATHETERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL MICROCATHETERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: GLOBAL MICRO GUIDEWIRES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL MICROCATHETERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 30: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 32: GLOBAL CAROTID ARTERY STENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: GLOBAL CAROTID ARTERY STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: GLOBAL FLOW DIVERSION STENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 35: GLOBAL FLOW DIVERSION STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 36: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 38: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 40: GLOBAL CLOT RETRIEVAL DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: GLOBAL CLOT RETRIEVAL DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 42: GLOBAL SUCTION AND ASPIRATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 43: GLOBAL SUCTION AND ASPIRATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 44: GLOBAL SNARES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL SNARES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 46: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 47: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 48: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 49: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 50: GLOBAL BALLOON OCCLUSION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 51: GLOBAL BALLOON OCCLUSION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 52: GLOBAL DISTAL FILTER DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 53: GLOBAL DISTAL FILTER DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 54: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 55: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 56: GLOBAL ANEURYSM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 57: GLOBAL ANEURYSM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 58: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 59: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 60: GLOBAL STENOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 61: GLOBAL STENOSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 62: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 63: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 64: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 65: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 66: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 67: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 68: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 69: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 70: NORTH AMERICANEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
TABLE 71: KEY PLAYERS OPERATING IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
TABLE 72: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 73: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 74: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
TABLE 75: KEY PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
TABLE 76: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 77: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 78: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
TABLE 79: KEY PLAYERS OPERATING IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
TABLE 80: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 81: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 82: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
TABLE 83: KEY PLAYERS OPERATING IN REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
TABLE 84: LIST OF MERGERS & ACQUISITIONS
TABLE 85: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 86: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 87: LIST OF BUSINESS EXPANSIONS & DIVESTITURES



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経血管デバイス/神経内視鏡手術の世界市場2023年〜2032年(GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の神経血管装置＆介入性神経放射線市場予測 2023年-2029年
  • 世界のインターベンション用神経装置市場予測 2023年-2029年
  • 神経装置の世界市場予測（～2030）
  • 網膜画像診断装置の世界市場2023年〜2032年
  • 神経デバイスの世界市場2022年～2029年：製品別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆